SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C-AR - Annual Report:
SEC Accession No. 0001493152-24-016259
Filing Date
2024-04-26
Accepted
2024-04-26 15:14:44
Documents
2
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 4083
2 ex-99.pdf EX-99 569815
  Complete submission text file 0001493152-24-016259.txt   790273
Mailing Address 194 CANDELERO DRIVE SUITE 223 HUMACAO PR 00791
Business Address 194 CANDELERO DRIVE SUITE 223 HUMACAO PR 00791 (415)-592-7399
Aspire BioPharma Inc. (Filer) CIK: 0001995528 (see all company filings)

IRS No.: 660991341 | State of Incorp.: PR | Fiscal Year End: 1231
Type: C-AR | Act: 33 | File No.: 020-33136 | Film No.: 24882799